Esophageal Diseases Clinical Trial
Official title:
Accuracy of Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases: A Multicenter Study
The purpose of the study is to determine the accuracy of detachable string magnetically controlled capsule endoscopy(DS-MCE) as a follow-up method for patients with previous esophageal diseases.
Esophagogastroduodenoscopy (EGD) is recognized as the gold standard for detection and follow-up of esophageal diseases,allowing for direct mucosal visualization and therapeutic intervention. EGD is however an invasive procedure and there is potential for procedure-related complications, such as perforation and bleeding.Esophageal capsule endoscopy(ECE)provides a novel noninvasive approach to visualize the esophagus.The main drawback for the use of ECE is its unreliable transit time which often renders an inadequate visualization of the esophagus.Thus investigators have developed the detachable string magnetically controlled capsule endoscopy(DS-MCE) which can control the movement of the capsule through the string. The ds-MCE system consists of two parts: the magnetically controlled capsule endoscopy (MCE) system and a transparent latex sleeve with a hollow string. The magnetically controlled capsule endoscopy (MCE) system (Ankon Technologies, Shanghai, China) detects focal lesions in the stomach with comparable accuracy with conventional EGD. One end of the hollow string is a transparent thin latex sleeve that can be wrapped on the surface of the capsule, and the other end of the string is connected to the syringe. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. In this case, investigator can examine the entire esophageal mucosa several times under real time views. The capsule then could be detached from the string system through injecting air into the hollow string with the syringe after completing the examination of esophagus. The pilot study of ds-MCE confirmed it was a feasible, safe and well-tolerated method for completely viewing esophagus and stomach, without the need for sedation. Besides, the 8-10h battery life of the ds-MCE enables complete examination of the small bowel, which provides the possibility for screening pathological changes in the entire gastrointestinal tract. This study is a prospective, multi-centered, diagnostic accuracy study. The primary outcome is the diagnostic accuracy of ds-MCE in identifying esophageal diseases. Second outcomes include the visualization and cleanliness of Z-line, safety and patient satisfaction of DS-MCE. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054933 -
Ultrasound Capsule Endoscopy for Esophagus Examination
|
N/A | |
Completed |
NCT04090554 -
Cytospongeâ„¢ Feasibility Study in Tanzania
|
N/A | |
Active, not recruiting |
NCT03962179 -
Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent)
|
N/A | |
Completed |
NCT03549494 -
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
|
Phase 2 | |
Recruiting |
NCT04481100 -
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
|
Phase 2 | |
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Completed |
NCT00977678 -
Drop in Gastroscopy - Experience After 9 Months
|
N/A | |
Recruiting |
NCT04068480 -
Esophageal and Gastric Diseases With Robotically Controlled Magnetic Capsule Endoscopy
|
||
Completed |
NCT00874263 -
Confocal Probe-based Endoscopic Imaging, Colorectal Cancer, Gastrointestinal (GI) Pathologies
|
N/A | |
Terminated |
NCT00442507 -
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
|
Phase 2 | |
Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
Withdrawn |
NCT02569073 -
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
|
Phase 4 | |
Recruiting |
NCT05252078 -
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
|
Phase 2 | |
Recruiting |
NCT00260585 -
Esophageal Cancer Risk Registry
|
||
Completed |
NCT03187314 -
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
|
Phase 2 | |
Recruiting |
NCT05004155 -
Twenty Four Hour Ambulatory pH & Impedance Testing: Normative Data for Indian Population
|
||
Recruiting |
NCT05877300 -
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
|
Phase 1 | |
Recruiting |
NCT03267355 -
Indications and Outcomes of Endoscopic Ultrasound in Tanta
|
N/A | |
Recruiting |
NCT05311787 -
The Strategy of Implementation of the ERAS Protocol After Esophageal Surgery
|
N/A | |
Recruiting |
NCT00939263 -
Development, Validation and Evaluation of an Adult and Pediatric Eosinophilic Esophagitis Activity Index
|
N/A |